X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2582) 2582
Publication (478) 478
Newsletter (82) 82
Book / eBook (69) 69
Book Review (59) 59
Book Chapter (34) 34
Conference Proceeding (17) 17
Magazine Article (9) 9
Dissertation (4) 4
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1970) 1970
hiv (1207) 1207
index medicus (1104) 1104
hiv-1 - drug effects (836) 836
animals (751) 751
human-immunodeficiency-virus (615) 615
virology (612) 612
anti-hiv agents - pharmacology (575) 575
immunology (563) 563
pharmacology & pharmacy (551) 551
hiv-1 (524) 524
immunodeficiency-virus type-1 (522) 522
molecular sequence data (507) 507
amino acid sequence (505) 505
hiv infections - drug therapy (490) 490
viruses (478) 478
human immunodeficiency virus--hiv (440) 440
hiv-1 - physiology (437) 437
aids (434) 434
cell line (425) 425
hiv fusion inhibitors - pharmacology (419) 419
infection (397) 397
virus diseases (380) 380
hiv infections - virology (379) 379
infectious diseases (377) 377
hiv envelope protein gp41 - pharmacology (371) 371
peptide fragments - pharmacology (371) 371
envelope glycoprotein (366) 366
biochemistry & molecular biology (362) 362
hiv-1 - genetics (361) 361
hiv envelope protein gp41 - chemistry (352) 352
hiv-1 - immunology (351) 351
proteins (347) 347
health aspects (336) 336
antiviral agents (328) 328
hiv envelope protein gp41 - metabolism (321) 321
research (314) 314
gp41 (309) 309
female (294) 294
hiv infection (277) 277
medicine, research & experimental (277) 277
peptides (264) 264
microbiology (263) 263
hiv envelope protein gp120 - metabolism (259) 259
hiv-1 - metabolism (258) 258
infections (256) 256
vaccines (254) 254
article (248) 248
hiv infections - immunology (246) 246
human immunodeficiency virus (245) 245
gp120 (242) 242
hiv envelope protein gp41 - genetics (233) 233
mice (229) 229
acquired immune deficiency syndrome--aids (224) 224
enfuvirtide (223) 223
analysis (218) 218
research article (209) 209
virus replication - drug effects (205) 205
anti-hiv agents - chemistry (201) 201
antibodies (201) 201
male (197) 197
multidisciplinary sciences (194) 194
aids vaccines - immunology (193) 193
in-vitro (191) 191
mutation (191) 191
hiv infections - prevention & control (188) 188
virus internalization - drug effects (188) 188
protein binding (187) 187
drug design (184) 184
medicine (184) 184
binding sites (183) 183
cells, cultured (182) 182
type-1 (182) 182
chemistry, medicinal (180) 180
models, molecular (180) 180
hiv envelope protein gp120 - immunology (174) 174
peptides - pharmacology (169) 169
entry inhibitors (167) 167
hiv envelope protein gp41 - immunology (162) 162
hiv antibodies - immunology (161) 161
drug resistance, viral (160) 160
anti-hiv agents - therapeutic use (158) 158
hiv envelope protein gp120 - chemistry (158) 158
binding (157) 157
cd4 antigens - metabolism (157) 157
entry (156) 156
hiv-1 - pathogenicity (156) 156
cell biology (155) 155
membrane-fusion (154) 154
fusion (151) 151
glycoproteins (151) 151
peptides - chemistry (150) 150
acquired immune deficiency syndrome (148) 148
membrane fusion - drug effects (148) 148
fusion inhibitor (147) 147
hiv fusion inhibitors - chemistry (142) 142
antiretroviral therapy (141) 141
protein conformation (141) 141
replication (141) 141
antiviral agents - pharmacology (140) 140
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (50) 50
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
UofT at Scarborough - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Toronto East General Hospital - Stacks (3) 3
UTL at Downsview - May be requested (3) 3
Credit Valley Hospital - Stacks (2) 2
Gerstein Science - Reference (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Online Resources - Online (2) 2
New College (Ivey) - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2725) 2725
Spanish (14) 14
Chinese (10) 10
French (4) 4
Japanese (4) 4
Russian (2) 2
Bosnian (1) 1
Danish (1) 1
German (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 03/2004, Volume 363, Issue 9413, pp. 938 - 947
Studies on the fusion-inhibitory peptides derived from the heptad repeat 1 and 2 (HR1 and HR2) regions of the HIV-1 envelope glycoprotein gp41 provided crucial... 
MEMBRANE-FUSION | MEDICINE, GENERAL & INTERNAL | GP41 CORE STRUCTURE | HIV-1 GP41 | ENVELOPE GLYCOPROTEIN | SYNTHETIC PEPTIDES | TYPE-1 GP41 | INFECTION IN-VITRO | COILED-COIL | ACUTE RESPIRATORY SYNDROME | POTENT INHIBITORS | Anti-HIV Agents - pharmacology | Surface Plasmon Resonance | Viral Envelope Proteins - pharmacology | Viral Fusion Proteins - metabolism | Membrane Glycoproteins - metabolism | Humans | Membrane Glycoproteins - chemistry | Protein Conformation - drug effects | HIV Envelope Protein gp41 - metabolism | Chromatography, High Pressure Liquid | HIV Envelope Protein gp41 - chemistry | SARS Virus - metabolism | HIV Envelope Protein gp41 - pharmacology | Viral Fusion Proteins - chemistry | HIV Envelope Protein gp41 - drug effects | Viral Envelope Proteins - metabolism | Severe Acute Respiratory Syndrome - metabolism | Circular Dichroism | Oligopeptides - chemistry | Membrane Fusion - drug effects | Electrophoresis, Polyacrylamide Gel | Membrane Glycoproteins - pharmacology | Cells, Cultured | SARS Virus - drug effects | Oligopeptides - metabolism | Severe Acute Respiratory Syndrome - drug therapy | SARS Virus - chemistry | Sequence Homology, Nucleic Acid | Spike Glycoprotein, Coronavirus | Anti-HIV Agents - chemistry | Severe Acute Respiratory Syndrome - prevention & control | Chemical Fractionation | Oligopeptides - drug effects | Viral Envelope Proteins - chemistry | Membrane Fusion - physiology | Reports | Usage | Diagnosis | Peptides | Severe acute respiratory syndrome | Pathology | Viruses | Membranes | Prophylaxis | Homology | Infections | Proteins | Hepatitis | Spectrum analysis | Human immunodeficiency virus--HIV | Dichroism | Docking | Electrophoresis | Inhibition | Sedimentation & deposition | Glycoprotein gp41 | Spike protein | Gel electrophoresis | Glycoprotein | Trimers | Liquid chromatography | Cell membranes | High-performance liquid chromatography | Sedimentation | Molecular chains | Helicity | Circular dichroism | Software | Surface plasmon resonance | Protein structure | High performance liquid chromatography
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0173454
The transmembrane envelope (TM) protein gp41 of the human immunodeficiency virus-1 (HIV-1) plays an important role during virus infection inducing the fusion... 
MULTIDISCIPLINARY SCIENCES | IN-VIVO | IL-10 PRODUCTION | MONOCYTES | INFECTION | HUMAN-IMMUNODEFICIENCY-VIRUS | HUMAN MONOCLONAL-ANTIBODIES | TYPE-1 | RECEPTOR ANTAGONIST | CELL-LINE | PEPTIDE | Antigens, Viral - pharmacology | Interferon-gamma | HIV Envelope Protein gp41 - genetics | HIV Envelope Protein gp41 - immunology | Humans | Protein Multimerization | Antigens, Viral - genetics | Mice, Transgenic | Recombinant Proteins - genetics | Recombinant Proteins - pharmacology | HIV-1 - genetics | Antigens, Viral - immunology | HIV Envelope Protein gp41 - pharmacology | HIV-1 - immunology | Animals | Recombinant Proteins - immunology | HEK293 Cells | Mice | CD8-Positive T-Lymphocytes - immunology | Immune Tolerance - drug effects | Physiological aspects | Genetic aspects | Research | Viral proteins | Gene expression | HIV (Viruses) | Membranes | Peptides | CD8 antigen | Viruses | Leukocytes (mononuclear) | Lymphocytes T | Infections | Proteins | Immunology | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Human immunodeficiency virus--HIV | Immunopathogenesis | Peripheral blood mononuclear cells | Inhibition | Enzyme-linked immunosorbent assay | Recombinant | Binding | Antigens | Immunoglobulins | Immune response | Cytokines | Glycoprotein gp41 | Envelope protein | Knowledge management | Trimers | Studies | Immunosuppression | Monocytes | γ-Interferon | Monoclonal antibodies | Homogeneity | Surface plasmon resonance | Mutation | Tumors | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2002, Volume 99, Issue 25, pp. 16249 - 16254
HIV entry inhibitors include coreceptor antagonists and the fusion inhibitor T-20. T-20 binds the first helical region (HR1) in the gp41 subunit of the viral... 
Cytometry | Biological Sciences | Receptors | HIV | Plasmids | Viruses | Amino acids | Infections | Kinetics | Cell fusion | HIV 1 | MEMBRANE-FUSION | MEDIATED FUSION | V3 LOOP | 6-HELIX BUNDLE | MULTIDISCIPLINARY SCIENCES | GP41 | IMMUNODEFICIENCY-VIRUS TYPE-1 | GP120 | CHEMOKINE RECEPTORS | CCR5 | DISEASE PROGRESSION | Anti-HIV Agents - pharmacology | HIV Envelope Protein gp120 - genetics | HIV Envelope Protein gp41 - genetics | Humans | Drug Resistance, Viral | HIV Envelope Protein gp41 - metabolism | Membrane Fusion - genetics | Peptide Fragments - pharmacology | HIV Envelope Protein gp120 - metabolism | Recombinant Fusion Proteins - metabolism | HIV Envelope Protein gp41 - pharmacology | Recombinant Fusion Proteins - antagonists & inhibitors | Receptors, CCR5 - metabolism | HIV-1 - physiology | Peptide Fragments - genetics | Membrane Fusion - drug effects | CCR5 Receptor Antagonists | Amides - pharmacology | Peptide Fragments - metabolism | HIV-1 - drug effects | Receptors, CXCR4 - antagonists & inhibitors | HIV-1 - genetics | Receptors, CXCR4 - metabolism | Animals | Genes, env | Peptide Fragments - antagonists & inhibitors | Protein Binding | Protein Conformation | Mice | HeLa Cells | 3T3 Cells | Amino Acid Substitution | CD4 Antigens - metabolism | Quaternary Ammonium Compounds - pharmacology | Physiological aspects | Membrane fusion | Viral envelopes | HIV (Viruses)
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2008, Volume 105, Issue 42, pp. 16332 - 16337
Journal Article
Journal Article
Journal Article